Katelyn Spence
Family · Meriden, CTNPI 1740601665
Payments from drug & device makers
Across 180 payments — averaging $19.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$387
- Novartis$257
- Bristol Myers Squibb$246
- AbbVie$216
- Pharmacyclics LLC, An Abbvie Company$214
- Pfizer$179
- plus $2K from 33 others
What the payments were for
- Food & beverage$3,431100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 21 | $387 |
| Novartis | 13 | $257 |
| Bristol Myers Squibb | 12 | $246 |
| AbbVie | 11 | $216 |
| Pharmacyclics LLC, An Abbvie Company | 10 | $214 |
| Pfizer | 11 | $179 |
| Sanofi | 9 | $159 |
| Incyte Corporation | 8 | $148 |
| Bayer | 5 | $124 |
| Lilly USA, LLC | 7 | $120 |
| Blueprint Medicines Corporation | 5 | $112 |
| Ipsen Biopharmaceuticals, Inc | 4 | $111 |
| Merck | 5 | $109 |
| Eisai Inc. | 5 | $92 |
| Seagen Inc. | 5 | $86 |
| Array Biopharma Inc | 4 | $81 |
| Astellas Pharma US Inc | 4 | $76 |
| GSK | 3 | $73 |
| Karyopharm Therapeutics Inc. | 3 | $53 |
| Epizyme, Inc. | 3 | $49 |
| Daiichi Sankyo Inc. | 3 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| AstraZeneca | 3 | $42 |
| Mirati Therapeutics, Inc. | 3 | $39 |
| Pharmaessentia USA Corporation | 2 | $39 |
| Amgen | 2 | $33 |
| AVEO Pharmaceuticals, Inc. | 2 | $33 |
| Stemline Therapeutics Inc. | 2 | $31 |
| Myriad Genetic Laboratories, Inc. | 2 | $30 |
| ADC Therapeutics America, Inc. | 1 | $29 |
| AMAG Pharmaceuticals, Inc. | 2 | $28 |
| Coherus Oncology, Inc. | 1 | $26 |
| Taiho Oncology, Inc. | 1 | $20 |
| CTI Biopharma Corp. | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Heron Therapeutics, Inc. | 1 | $16 |
| Exelixis Inc. | 1 | $16 |
| Beigene USA, Inc. | 1 | $12 |
How this compares
$3,431 in reported general payments places this provider in the 85th percentile of 1,596 family providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CalquenceAcalabrutinib Maleate | 11 | $164,358 |
| ErleadaApalutamide | 11 | $162,383 |
| XareltoRivaroxaban | 21 | $16,539 |
| Xtampza ErOxycodone Myristate | 12 | $7,433 |
| Oxycodone Hcl | 52 | $648 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 15 | $211 |
| Prochlorperazine Maleate | 11 | $198 |
| Prednisone | 17 | $95 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonErleada, Xarelto | $387 | $178,92132 claims |
| AstraZenecaCalquence | $42 | $164,35811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,596 family providers in Connecticut.
Other family in Meriden
- Christina MuleMeriden$13K
- Elisha ChristiansonWaterbury$371K
- Kathryn TierneyNew Britain$140K
- Jennifer SilvaSouth Windsor$91K
- Carli WillardEnfield$74K
- Erin MartinMilford$70K
- Dayna GiordanoNew Haven$65K
- Diana BytyqiDerby$53K
- Farhiya AbdiSouth Windsor$30K
- Nicole SandilandsBridgeport$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.